Articles On Sigma Healthcare (ASX:SIG)

By Greg Peel, Acting Editor FNArena Guide: The FNArena database tabulates the views of seven major Australian and international stock brokers: Citi, Credit Suisse, Macquarie, Morgan Stanley, Morgans, Ord Minnett and UBS. For the pu...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

On Monday I looked at three ASX shares that have been given buy ratings by leading brokers this week. Unfortunately, not all shares are in favour with brokers right now. The three shares listed below have all just been given sell ratings....

“While mergers are much like marriage and de-mergers are like divorce, the constructive efforts of both parties are highly desired to taste any fruitful outcome.” Merging of two businesses sounds interesting, and in most cases, markets reac...

The S&P/ASX 200 index is struggling to keep its head above water in afternoon trade. At the time of writing the benchmark index is down slightly to 6,846.2 points. Four shares that are falling more than most today are listed below. Her...

It’s been an up and down start to December for ASX 200 shares. The S&P/ASX 200 Index (INDEXASX: XJO) has edged just 0.05% higher as we head towards the Christmas/New Year period. But while there have been some winners such as Lynas Cor...

Sigma Healthcare has adjusted guidance to account for the renewed Chemist Warehouse contract, while Australian Pharmaceutical Industries finally takes its hat out of the merger ring. -Downgrades FY20 guidance to reflect investment in new...

ShareCafeOvernight: Buy It Anyway World Overnight SPI Overnight (Dec) 6877.00 + 28.00 0.41% S&P ASX 200 6849.70 + 110.00 1.63% S&P500 3191.45 + 22.65 0.71% Nasdaq Comp 8814.23 + 79.35 0.91% DJIA 28235.89 + 100.51 0.36%...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

ShareCafeAPI – Credit Suisse rates the stock as Underperform Australian Pharmaceutical has sold its 12.96% stake in Sigma Healthcare ((SIG)) for $0.60 a share. Credit Suisse calculates this represents a -$3.5m loss vs the price of the acqui...

World Overnight SPI Overnight (Dec) 6877.00 + 28.00 0.41% S&P ASX 200 6849.70 + 110.00 1.63% S&P500 3191.45 + 22.65 0.71% Nasdaq Comp 8814.23 + 79.35 0.91% DJIA 28235.89 + 100.51 0.36% S&P500 VIX 12.14 – 0.49 – 3.8...

Shares in pharmacy distributor Sigma Healthcare slumped almost 10 per cent on Monday after rival API sold its entire 11 per cent stake.

The S&P/ASX 200 index is on course to start the week on a very positive note. In afternoon trade the benchmark index is up a sizeable 1.5% to 6,839.7 points. Four shares that have failed to follow the market higher today are listed bel...

Australian Pharmaceuticals Industries Limited (ASX: API) has sold its stake in Sigma Healthcare Limited. The company sold whole interest in Sigma and now it holds no shares in Sigma. Selling stake in Sigma will allow API to increase its f...

16 Dec 2019 - Australian Pharmaceutical Industries (ASX:API) has sold all of its shares in said that it had today Sigma Healthcare.

The Sigma Healthcare Ltd (ASX: SIG) share price is starting the week deep in the red. In morning trade the pharmacy chain operator and distributor’s shares are down 8% to 60.7 cents. Why is the Sigma Healthcare share price sinking lower to...

  Sigma Healthcare Limited (ASX:SIG) announced the FY20 EBITDA guidance after the announcement on new first-line agreement with My Chemist/Chemist Warehouse Group (MC/CW Group). The new agreement will lift the annualised sales by $700 – $80...

Australian Pharmaceutical Industries – which owns the Priceline Pharmacy chain and Clear Skincare clinics – is seeking a buyer for its Sigma Healthcare stake, Street Talk understands. 

The Next Science Ltd (ASX: NXS) share price is on course to end the week on a high. In morning trade the medical technology company’s shares are racing 9% higher to $1.84. Today’s gain means that Next Science’s shares have now rallied a re...

In morning trade the Sigma Healthcare Ltd (ASX: SIG) share price has charged higher following the release of a market update. At the time of writing the pharmacy chain operator and distributor’s shares are up 6% to 67.5 cents. What was in...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

By Rudi Filapek-Vandyck, Editor FNArena Guide: The FNArena database tabulates the views of seven major Australian and international stock brokers: Citi, Credit Suisse, Macquarie, Morgan Stanley, Morgans, Ord Minnett and UBS. For th...

Australian healthcare system is vast, and it has many healthcare service providers with their roots in drug development, imaging solutions, pathology, medical devices, distribution, among other areas. The healthcare system in Australia is r...

The S&P/ASX 200 index has given back the majority of its morning gains and is trading just a fraction higher this afternoon. At the time of writing the benchmark index is up slightly at 6,868.6 points. Four shares that have failed to f...

The S&P/ASX 200 index is pushing higher again on Thursday. In afternoon trade the benchmark index is on course to record another solid gain and is up 0.25% to 6,867.4 points. Four shares that have failed to follow the market higher tod...

G8 Education Ltd (ASX: GEM) shares have had a tough month in November. The childcare group’s share price has plummeted 22.96% lower this month after a weak trading update on 15 November. What sent G8 Education shares tumbling? G8 Educatio...

Sigma Healthcare Ltd (ASX: SIG) shares have been one of the top performers throughout the month of November. It’s been a rollercoaster of a ride for much of the ASX 200 this month. The S&P/ASX 200 Index (INDEXASX: XJO) fell lower in th...

The Australian Medicare is the foundation of the health care system since 1984 and has three major divisions- public hospitals, medical services and medicines. One of the essential parts of Medicare is the Pharmaceutical Benefits Scheme (PB...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

In the Australian health care sector, the advancement in medical science have completely changed the health care services. New and advanced technologies have a high impact on medical and health services. These technologies are improving the...

World Overnight SPI Overnight (Dec) 6769.00 + 27.00 0.40% S&P ASX 200 6731.40 + 21.60 0.32% S&P500 3133.64 + 23.35 0.75% Nasdaq Comp 8632.49 + 112.60 1.32% DJIA 28066.47 + 190.85 0.68% S&P500 VIX 11.87 – 0.47 – 3.8...

25 Nov 2019 - Sigma Healthcare (ASX:SIG) has reached an agreement with the My Chemist/Chemist Warehouse Group (MC/CW Group) for the supply of Fast Moving Consumer Goods.

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

The Alcidion Group Ltd (ASX: ALC) share price has been a positive performer on Tuesday. In morning trade the healthcare technology company’s shares were up 8% to 20.5 cents at one stage. Why did the Alcidion share price surge higher? Inves...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished higher on Friday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) higher 0.87% to...

15 Nov 2019 - A subsidiary of Cronos Australia (ASX:CAU) has executed a distribution agreement with a subsidiary of Sigma Healthcare (ASX:SIG).

Within a week of listing on the ASX an Australian medicinal cannabis joint venture (JV) backed by a Canadian colossus has signed a distribution deal with Sigma Healthcare (ASX: SIG). The agreement will see Cronos Australia's (ASX: CAU) im...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

Digital medication company MedAdvisor (ASX: MDR) has further extended its operations within the growing “ePrescribing” market, following a new two-year deal worth around $1 million per year with pharmacy retail group Sigma Healthcare. Sigma...

07 Nov 2019 - MedAdvisor (ASX:MDR), Australia’s leading digital medication management company, has signed a new 2-year agreement with pharmacy retail group, Sigma Healthcare (ASX:S…

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

An ASX market update saw the Sigma Healthcare Ltd  (ASX: SIG) share price close 5.17% higher on Friday afternoon at $0.61 per share. Sigma confirmed market speculation surrounding negotiation with Chemist Warehouse Group for the supply of...

Sigma Healthcare (ASX: SIG) shares will be on watch today after making an announcement after the market had closed on Friday last week. Sigma Pharmaceuticals is a pharmacy distribution business and the name behind Amcal, Chemist King, Disco...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

Sigma Healthcare Limited’s (ASX: SIG) half year results were in line with the expectation of the company. Ongoing revenue was up by 6.9% for the first half. The company reported an underlying EBITDA of $31.9 million. Project Pivot is on t...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...